{"entity":{"type":"insider","cik":"0001825216","url":"/insider/0001825216","json_url":"/insider/0001825216.json","name":"Alland Leila","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":12,"first":"2021-04-08","last":"2026-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Alland Leila","source":"filing","n_filings":12,"first_seen":"2021-04-08","last_seen":"2026-07-02"}],"transactions":[{"id":5740552,"accession":"0001493152-26-031906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-031906","line_url":"/filing/0001493152-26-031906#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":5.917,"price_display":"5.92","price_state":"stated","total_value":65087.0,"total_display":"65,087.00","total_whole":"65,087","shares_owned_after":162614.0,"shares_owned_after_display":"162,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":5932669,"accession":"0001493152-26-004761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-004761","line_url":"/filing/0001493152-26-004761#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18065.0,"shares_display":"18,065","price_per_share":5.0906,"price_display":"5.09","price_state":"stated","total_value":91961.689,"total_display":"91,961.69","total_whole":"91,962","shares_owned_after":173614.0,"shares_owned_after_display":"173,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":2911830,"accession":"0001493152-24-020542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-020542","line_url":"/filing/0001493152-24-020542#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":4.709,"price_display":"4.71","price_state":"stated","total_value":51799.0,"total_display":"51,799.00","total_whole":"51,799","shares_owned_after":82857.0,"shares_owned_after_display":"82,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":8591015,"accession":"0001493152-23-034854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034854","line_url":"/filing/0001493152-23-034854#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7246.0,"shares_display":"7,246","price_per_share":3.9014,"price_display":"3.90","price_state":"stated","total_value":28269.5444,"total_display":"28,269.54","total_whole":"28,270","shares_owned_after":71857.0,"shares_owned_after_display":"71,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8116741,"accession":"0001209191-23-049751","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049751","line_url":"/filing/0001209191-23-049751#line-1","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6291.0,"shares_display":"6,291","price_per_share":6.62,"price_display":"6.62","price_state":"stated","total_value":41646.42,"total_display":"41,646.42","total_whole":"41,646","shares_owned_after":45909.0,"shares_owned_after_display":"45,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":5202606,"accession":"0001209191-21-055438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055438","line_url":"/filing/0001209191-21-055438#line-2","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":30.25,"price_display":"30.25","price_state":"stated","total_value":3025.0,"total_display":"3,025.00","total_whole":"3,025","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-10","scope":"insider"},{"id":5336669,"accession":"0001209191-21-055140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055140","line_url":"/filing/0001209191-21-055140#line-2","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":30.25,"price_display":"30.25","price_state":"stated","total_value":117975.0,"total_display":"117,975.00","total_whole":"117,975","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-08","scope":"insider"},{"id":4275869,"accession":"0001209191-21-050670","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-050670","line_url":"/filing/0001209191-21-050670","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4471.0,"shares_display":"4,471","price_per_share":34.042082509505704,"price_display":"34.04","price_state":"stated","total_value":152202.1509,"total_display":"152,202.15","total_whole":"152,202","shares_owned_after":1802.0,"shares_owned_after_display":"1,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider","n_lines":3},{"id":4571786,"accession":"0001209191-21-045989","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-045989","line_url":"/filing/0001209191-21-045989","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":32.30327635,"price_display":"32.30","price_state":"stated","total_value":129213.1054,"total_display":"129,213.11","total_whole":"129,213","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider","n_lines":2},{"id":5251013,"accession":"0001209191-21-039035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-039035","line_url":"/filing/0001209191-21-039035","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.596709075,"price_display":"33.60","price_state":"stated","total_value":134386.8363,"total_display":"134,386.84","total_whole":"134,387","shares_owned_after":1367.0,"shares_owned_after_display":"1,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-08","scope":"insider","n_lines":2},{"id":4139310,"accession":"0001209191-21-031300","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-031300","line_url":"/filing/0001209191-21-031300","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":34.82721945,"price_display":"34.83","price_state":"stated","total_value":139308.8778,"total_display":"139,308.88","total_whole":"139,309","shares_owned_after":158.0,"shares_owned_after_display":"158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-10","scope":"insider","n_lines":2},{"id":4225829,"accession":"0001209191-21-026064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-026064","line_url":"/filing/0001209191-21-026064","is_derivative":false,"issuer_cik":"0001699382","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001699382","owner_cik":"0001825216","owner_name":"Alland Leila","owner_display_name":"Alland Leila","owner_url":"/insider/0001825216","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.8611473,"price_display":"33.86","price_state":"stated","total_value":135444.5892,"total_display":"135,444.59","total_whole":"135,445","shares_owned_after":28.0,"shares_owned_after_display":"28","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Director","n_filings":4,"first_seen":"2023-09-29","last_seen":"2026-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Officer (Chief Medical Officer)","n_filings":8,"first_seen":"2021-04-08","last_seen":"2023-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825216","retrieved_at":"2026-08-25T15:00:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}